Literature DB >> 24623762

Genetic suppression of transgenic APP rescues Hypersynchronous network activity in a mouse model of Alzeimer's disease.

Heather A Born1, Ji-Yoen Kim, Ricky R Savjani, Pritam Das, Yuri A Dabaghian, Qinxi Guo, Jong W Yoo, Dorothy R Schuler, John R Cirrito, Hui Zheng, Todd E Golde, Jeffrey L Noebels, Joanna L Jankowsky.   

Abstract

Alzheimer's disease (AD) is associated with an elevated risk for seizures that may be fundamentally connected to cognitive dysfunction. Supporting this link, many mouse models for AD exhibit abnormal electroencephalogram (EEG) activity in addition to the expected neuropathology and cognitive deficits. Here, we used a controllable transgenic system to investigate how network changes develop and are maintained in a model characterized by amyloid β (Aβ) overproduction and progressive amyloid pathology. EEG recordings in tet-off mice overexpressing amyloid precursor protein (APP) from birth display frequent sharp wave discharges (SWDs). Unexpectedly, we found that withholding APP overexpression until adulthood substantially delayed the appearance of epileptiform activity. Together, these findings suggest that juvenile APP overexpression altered cortical development to favor synchronized firing. Regardless of the age at which EEG abnormalities appeared, the phenotype was dependent on continued APP overexpression and abated over several weeks once transgene expression was suppressed. Abnormal EEG discharges were independent of plaque load and could be extinguished without altering deposited amyloid. Selective reduction of Aβ with a γ-secretase inhibitor has no effect on the frequency of SWDs, indicating that another APP fragment or the full-length protein was likely responsible for maintaining EEG abnormalities. Moreover, transgene suppression normalized the ratio of excitatory to inhibitory innervation in the cortex, whereas secretase inhibition did not. Our results suggest that APP overexpression, and not Aβ overproduction, is responsible for EEG abnormalities in our transgenic mice and can be rescued independently of pathology.

Entities:  

Keywords:  EEG; amyloid precursor protein; epilepsy; seizure; sharp wave discharge; transgene suppression

Mesh:

Substances:

Year:  2014        PMID: 24623762      PMCID: PMC3951689          DOI: 10.1523/JNEUROSCI.5171-13.2014

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  69 in total

1.  BACE1 deficiency causes altered neuronal activity and neurodegeneration.

Authors:  Xiangyou Hu; Xiangdong Zhou; Wanxia He; Jun Yang; Wencheng Xiong; Philip Wong; Christopher G Wilson; Riqiang Yan
Journal:  J Neurosci       Date:  2010-06-30       Impact factor: 6.167

Review 2.  Alzheimer's secretases regulate voltage-gated sodium channels.

Authors:  Dora M Kovacs; Manuel T Gersbacher; Doo Yeon Kim
Journal:  Neurosci Lett       Date:  2010-09-15       Impact factor: 3.046

3.  Mapping loci for pentylenetetrazol-induced seizure susceptibility in mice.

Authors:  T N Ferraro; G T Golden; G G Smith; P St Jean; N J Schork; N Mulholland; C Ballas; J Schill; R J Buono; W H Berrettini
Journal:  J Neurosci       Date:  1999-08-15       Impact factor: 6.167

4.  Reduced sodium channel Na(v)1.1 levels in BACE1-null mice.

Authors:  Doo Yeon Kim; Manuel T Gersbacher; Perrine Inquimbert; Dora M Kovacs
Journal:  J Biol Chem       Date:  2010-12-29       Impact factor: 5.157

5.  Amyloid beta-induced neuronal hyperexcitability triggers progressive epilepsy.

Authors:  Rimante Minkeviciene; Sylvain Rheims; Marton B Dobszay; Misha Zilberter; Jarmo Hartikainen; Lívia Fülöp; Botond Penke; Yuri Zilberter; Tibor Harkany; Asla Pitkänen; Heikki Tanila
Journal:  J Neurosci       Date:  2009-03-18       Impact factor: 6.167

6.  Neuregulin 1 regulates pyramidal neuron activity via ErbB4 in parvalbumin-positive interneurons.

Authors:  Lei Wen; Yi-Sheng Lu; Xin-Hong Zhu; Xiao-Ming Li; Ran-Sook Woo; Yong-Jun Chen; Dong-Min Yin; Cary Lai; Alvin V Terry; Almira Vazdarjanova; Wen-Cheng Xiong; Lin Mei
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-29       Impact factor: 11.205

7.  Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease.

Authors:  Jorge J Palop; Jeannie Chin; Erik D Roberson; Jun Wang; Myo T Thwin; Nga Bien-Ly; Jong Yoo; Kaitlyn O Ho; Gui-Qiu Yu; Anatol Kreitzer; Steven Finkbeiner; Jeffrey L Noebels; Lennart Mucke
Journal:  Neuron       Date:  2007-09-06       Impact factor: 17.173

8.  BACE1 gene deletion: impact on behavioral function in a model of Alzheimer's disease.

Authors:  Dione Kobayashi; Michelle Zeller; Tracy Cole; Manuel Buttini; Lisa McConlogue; Sukanto Sinha; Stephen Freedman; Richard G M Morris; Karen S Chen
Journal:  Neurobiol Aging       Date:  2007-02-28       Impact factor: 4.673

9.  Biology and pathophysiology of the amyloid precursor protein.

Authors:  Hui Zheng; Edward H Koo
Journal:  Mol Neurodegener       Date:  2011-04-28       Impact factor: 14.195

10.  Modeling Alzheimer's disease in mouse without mutant protein overexpression: cooperative and independent effects of Aβ and tau.

Authors:  Qinxi Guo; Hongmei Li; Allysa L Cole; Ji-Yeun Hur; Yueming Li; Hui Zheng
Journal:  PLoS One       Date:  2013-11-20       Impact factor: 3.240

View more
  74 in total

1.  Opposite Dysregulation of Fragile-X Mental Retardation Protein and Heteronuclear Ribonucleoprotein C Protein Associates with Enhanced APP Translation in Alzheimer Disease.

Authors:  Antonella Borreca; Katia Gironi; Giusy Amadoro; Martine Ammassari-Teule
Journal:  Mol Neurobiol       Date:  2015-06-06       Impact factor: 5.590

2.  Neuronal Network Excitability in Alzheimer's Disease: The Puzzle of Similar versus Divergent Roles of Amyloid β and Tau.

Authors:  Syed Faraz Kazim; Joon Ho Seo; Riccardo Bianchi; Chloe S Larson; Abhijeet Sharma; Robert K S Wong; Kirill Y Gorbachev; Ana C Pereira
Journal:  eNeuro       Date:  2021-04-23

Review 3.  Epileptic activity in Alzheimer's disease: causes and clinical relevance.

Authors:  Keith A Vossel; Maria C Tartaglia; Haakon B Nygaard; Adam Z Zeman; Bruce L Miller
Journal:  Lancet Neurol       Date:  2017-04       Impact factor: 44.182

4.  Shedding the epilepsy comorbidity in Alzheimer's disease.

Authors:  Elizabeth M Powell
Journal:  Epilepsy Curr       Date:  2014-07       Impact factor: 7.500

Review 5.  Network abnormalities and interneuron dysfunction in Alzheimer disease.

Authors:  Jorge J Palop; Lennart Mucke
Journal:  Nat Rev Neurosci       Date:  2016-11-10       Impact factor: 34.870

6.  Sphingosine Kinase 2 Potentiates Amyloid Deposition but Protects against Hippocampal Volume Loss and Demyelination in a Mouse Model of Alzheimer's Disease.

Authors:  Mona Lei; Jonathan D Teo; Huitong Song; Holly P McEwen; Jun Yup Lee; Timothy A Couttas; Thomas Duncan; Rose Chesworth; Josefine Bertz; Magdalena Przybyla; Janet Van Eersel; Benjamin Heng; Gilles J Guillemin; Lars M Ittner; Thomas Fath; Brett Garner; Arne Ittner; Tim Karl; Anthony S Don
Journal:  J Neurosci       Date:  2019-10-22       Impact factor: 6.167

Review 7.  Epilepsy as a Network Disorder (2): What can we learn from other network disorders such as dementia and schizophrenia, and what are the implications for translational research?

Authors:  Helen E Scharfman; Andres M Kanner; Alon Friedman; Ingmar Blümcke; Candice E Crocker; Fernando Cendes; Ramon Diaz-Arrastia; Hans Förstl; André A Fenton; Anthony A Grace; Jorge Palop; Jason Morrison; Astrid Nehlig; Asuri Prasad; Karen S Wilcox; Nathalie Jette; Bernd Pohlmann-Eden
Journal:  Epilepsy Behav       Date:  2017-10-31       Impact factor: 2.937

8.  Inhibitory Parvalbumin Basket Cell Activity is Selectively Reduced during Hippocampal Sharp Wave Ripples in a Mouse Model of Familial Alzheimer's Disease.

Authors:  Adam Caccavano; P Lorenzo Bozzelli; Patrick A Forcelli; Daniel T S Pak; Jian-Young Wu; Katherine Conant; Stefano Vicini
Journal:  J Neurosci       Date:  2020-05-21       Impact factor: 6.167

9.  Anti-Aβ antibodies incapable of reducing cerebral Aβ oligomers fail to attenuate spatial reference memory deficits in J20 mice.

Authors:  Alexandra J Mably; Wen Liu; Jessica M Mc Donald; Jean-Cosme Dodart; Frédérique Bard; Cynthia A Lemere; Brian O'Nuallain; Dominic M Walsh
Journal:  Neurobiol Dis       Date:  2015-07-26       Impact factor: 5.996

10.  Evidence for Alzheimer's disease-linked synapse loss and compensation in mouse and human hippocampal CA1 pyramidal neurons.

Authors:  Krystina M Neuman; Elizabeth Molina-Campos; Timothy F Musial; Andrea L Price; Kwang-Jin Oh; Malerie L Wolke; Eric W Buss; Stephen W Scheff; Elliott J Mufson; Daniel A Nicholson
Journal:  Brain Struct Funct       Date:  2014-07-17       Impact factor: 3.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.